Sragovich, Shlomo
Malishkevich, Anna
Piontkewitz, Yael
Giladi, Eliezer
Touloumi, Olga
Lagoudaki, Roza
Grigoriadis, Nikolaos
Gozes, Illana http://orcid.org/0000-0001-9796-2430
Funding for this research was provided by:
Israel Science Foundation (1424/14)
United States - Israel Binational Science Foundation (2016746)
ERA-NET Neuron, AMN Foundation, Israeli Ministry of Science.
Article History
Received: 30 August 2018
Revised: 24 October 2018
Accepted: 9 December 2018
First Online: 15 January 2019
Conflict of interest
: I.G. is the Chief Scientific Officer of Coronis Neurosciences, developing CP201 for the <i>ADNP</i> syndrome. NAP (CP201) use and formulation is under patent protection.